BioSpace News Archive

Policy

Germany Approves Novel Cell Therapy Extracted from Skin

RHEACELL, a German biopharmaceutical company focused on clinical development of novel stem cell therapeutics, has been granted national approval under § 4b of the German Medicinal Products Act for its novel cell therapy product AMESANAR.

October 6, 2021
·
3 min read
Business

Caris Life Sciences Announces Appointment of Mike Weinstein, Medical Technology Executive and Wall Street Veteran, as Chief Financial Officer

Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, announced the appointment of Mike Weinstein as Executive Vice President and Chief Financial Officer.

October 6, 2021
·
4 min read
Drug Development

Retrotope Reports Data from Phase 2/3 Clinical Trial of RT001 and Concurrent Natural History Study in Patients with Infantile Neuroaxonal Dystrophy (INAD)

Retrotope today reported data from its Phase 2/3 clinical trial of RT001 in patients with infantile neuroaxonal dystrophy (INAD) and its concurrent natural history study of disease onset and progression in INAD patients.

October 6, 2021
·
9 min read
BioCapital

Landos Biopharma Announces Publication in Scientific Reports of Novel Preclinical Findings Demonstrating Omilancor’s Therapeutic Potential in Models of Psoriasis and Further Validating the LANCL2 Mechanism

Landos Biopharma, Inc. today announced the publication of a peer-reviewed article titled “First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of the LANCL2 pathway in psoriasis” in Scientific Reports.

October 6, 2021
·
7 min read
Business

Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs

Voyager receives $30 million up front with potential option exercise fees and milestone payments of up to $600 million plus product sales-based royalties

October 6, 2021
·
7 min read
Genetown

Microbot Medical Secures Patent for LIBERTY® Robotic System in the United States

Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance covering the Company’s LIBERTY® Robotic System.

October 6, 2021
·
3 min read
Business

Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) will release its third-quarter 2021 financial results on Tuesday, Nov. 2, 2021

October 6, 2021
·
1 min read
Business

RedHill Biopharma’s Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements

Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior authorization is an important expansion of coverage for California patients and continues to increase Talicia’s overall unrestricted coverage

October 6, 2021
·
11 min read
Business

Codagenix Announces Appointment of Two New Members to its Board of Directors

Codagenix, Inc. this week announced the appointment of two new members to its Board of Directors each with significant biotechnology and life sciences experience, Lori Rudolph-Owen , Ph.D., and Jill Howe .

October 6, 2021
·
2 min read
Deals

Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion

October 6, 2021
·
6 min read